Inventor profile of:

John BLANKENSHIP

City:

Acton, Massachusetts

Country:

United States

Published Applications:

15

Last publication date:

2026-02-05

Top Assignees for applications by John BLANKENSHIP

The entities that hold a legal rights for patent applications filed by inventor BLANKENSHIP John:

Recent patent applications by BLANKENSHIP John

John BLANKENSHIP from Acton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-05
US20260035473A1
Chemistry; metallurgy

BINDING MOLECULES AGAINST BCMA AND USES THEREOFPrivate view

#2 | 2026-02-05
US20260034195A1
Human necessities

CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

#3 | 2024-09-19
US20240309084A1
Chemistry; metallurgy

DEGRADATION OF EXTRACELLULAR TARGETS

#4 | 2023-12-28
US20230416390A1
Chemistry; metallurgy

BCMA CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

#5 | 2023-09-21
US20230295322A1
Chemistry; metallurgy

Binding molecules against BCMA and uses thereof

#6 | 2023-08-10
US20230250179A1
Chemistry; metallurgy

BCMA chimeric antigen receptors and uses thereof

#7 | 2023-08-03
US20230242647A1
Chemistry; metallurgy

ENGINEERED IMMUNOGLOBULINS

#8 | 2023-06-15
US20230183368A1
Chemistry; metallurgy

BCMA chimeric antigen receptors and uses thereof

#9 | 2023-06-01
US20230167193A1
Chemistry; metallurgy

IMMUNOGLOBULIN VARIANTS

#10 | 2022-12-15
US20220396631A1
Chemistry; metallurgy

TRISPECIFIC BINDING MOLECULES AGAINST BCMA AND USES THEREOF

#11 | 2022-11-17
US20220364055A1
Chemistry; metallurgy

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

#12 | 2022-10-20
US20220332821A1
Chemistry; metallurgy

DOSING REGIMEN AND COMBINATION THERAPIES FOR MULTISPECIFIC ANTIBODIES TARGETING B-CELL MATURATION ANTIGEN

#13 | 2021-07-22
US20210220404A1
Human necessities

CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

#14 | 2019-12-19
US20190382500A1
Chemistry; metallurgy

BCMA chimeric antigen receptors and uses thereof

#15 | 2019-12-05
US20190367628A1
Chemistry; metallurgy

Binding molecules against BCMA and uses thereof

InventorID:

3045206 ⎘